SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE
Generic: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE
Advagen Pharma Ltd.Manufacturer
ORALRoute
SPIRONOLACTONEActive Substance
2026-09-10Original Approval
SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE is FDA application ANDA220884, sponsored by RUBICON RESEARCH. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DYSPNOEA
99 reports
2
FATIGUE
75 reports
3
HEADACHE
73 reports
4
NAUSEA
72 reports
5
DIARRHOEA
70 reports
6
DIZZINESS
55 reports
7
COUGH
51 reports
8
PAIN
45 reports
9
INFUSION SITE PAIN
41 reports
10
OFF LABEL USE
40 reports